Thioamides  ||| S:0 E:11 ||| NNP
as  ||| S:11 E:14 ||| IN
radical  ||| S:14 E:22 ||| JJ
scavenging  ||| S:22 E:33 ||| JJ
compounds ||| S:33 E:42 ||| NN
:  ||| S:42 E:44 ||| :
Methods  ||| S:44 E:52 ||| NNP
for  ||| S:52 E:56 ||| IN
screening  ||| S:56 E:66 ||| VBG
antioxidant  ||| S:66 E:78 ||| JJ
activity  ||| S:78 E:87 ||| NN
and  ||| S:87 E:91 ||| CC
detection  ||| S:91 E:101 ||| JJ
Heteroaromatic  ||| S:101 E:116 ||| JJ
thiols  ||| S:116 E:123 ||| NN
and  ||| S:123 E:127 ||| CC
thiones  ||| S:127 E:135 ||| NNS
attracted  ||| S:135 E:145 ||| VBD
the  ||| S:145 E:149 ||| DT
attention  ||| S:149 E:159 ||| NN
of  ||| S:159 E:162 ||| IN
chemists ||| S:162 E:170 ||| NNS
,  ||| S:170 E:172 ||| ,
pharmacologists  ||| S:172 E:188 ||| NN
and  ||| S:188 E:192 ||| CC
biochemists  ||| S:192 E:204 ||| NN
because  ||| S:204 E:212 ||| IN
of  ||| S:212 E:215 ||| IN
participation  ||| S:215 E:229 ||| NN
in  ||| S:229 E:232 ||| IN
the  ||| S:232 E:236 ||| DT
interception  ||| S:236 E:249 ||| NN
of  ||| S:249 E:252 ||| IN
free  ||| S:252 E:257 ||| JJ
radicals ||| S:257 E:265 ||| NNS
.  ||| S:265 E:267 ||| .
For  ||| S:267 E:271 ||| IN
the  ||| S:271 E:275 ||| DT
first  ||| S:275 E:281 ||| JJ
time  ||| S:281 E:286 ||| NN
offered  ||| S:286 E:294 ||| VBD
independent  ||| S:294 E:306 ||| JJ
and  ||| S:306 E:310 ||| CC
reliable  ||| S:310 E:319 ||| JJ
methods  ||| S:319 E:327 ||| NNS
for  ||| S:327 E:331 ||| IN
evaluating  ||| S:331 E:342 ||| VBG
of  ||| S:342 E:345 ||| IN
the  ||| S:345 E:349 ||| DT
antioxidant  ||| S:349 E:361 ||| JJ
activity  ||| S:361 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
thioamides-derivatives  ||| S:373 E:396 ||| JJ
of  ||| S:396 E:399 ||| IN
pyridine ||| S:399 E:407 ||| NN
,  ||| S:407 E:409 ||| ,
quinoline ||| S:409 E:418 ||| NN
,  ||| S:418 E:420 ||| ,
imidazole ||| S:420 E:429 ||| NN
,  ||| S:429 E:431 ||| ,
triazole ||| S:431 E:439 ||| NN
,  ||| S:439 E:441 ||| ,
tetrazole ||| S:441 E:450 ||| NN
,  ||| S:450 E:452 ||| ,
pyrimidine ||| S:452 E:462 ||| NN
,  ||| S:462 E:464 ||| ,
pyrrolidine  ||| S:464 E:476 ||| NN
and  ||| S:476 E:480 ||| CC
7-mercapto-4-methylcoumarin  ||| S:480 E:508 ||| CD
-based  ||| S:508 E:515 ||| NN
on  ||| S:515 E:518 ||| IN
kinetic  ||| S:518 E:526 ||| JJ
parameters  ||| S:526 E:537 ||| NNS
of  ||| S:537 E:540 ||| IN
the  ||| S:540 E:544 ||| DT
thioamide  ||| S:544 E:554 ||| JJ
reaction  ||| S:554 E:563 ||| NN
with  ||| S:563 E:568 ||| IN
chromogenic  ||| S:568 E:580 ||| JJ
radical  ||| S:580 E:588 ||| JJ
( ||| S:588 E:589 ||| -LRB-
rate  ||| S:589 E:594 ||| NN
constant ||| S:594 E:602 ||| NN
,  ||| S:602 E:604 ||| ,
M ||| S:604 E:605 ||| NNP
( ||| S:605 E:606 ||| -LRB-
-1 ||| S:606 E:608 ||| NNP
) ||| S:608 E:609 ||| -RRB-
min ||| S:609 E:612 ||| NNS
( ||| S:612 E:613 ||| -LRB-
-1 ||| S:613 E:615 ||| NNP
)  ||| S:615 E:617 ||| -RRB-
and  ||| S:617 E:621 ||| CC
time  ||| S:621 E:626 ||| NN
to  ||| S:626 E:629 ||| TO
decrease  ||| S:629 E:638 ||| VB
concentration  ||| S:638 E:652 ||| NN
of  ||| S:652 E:655 ||| IN
test  ||| S:655 E:660 ||| NN
free  ||| S:660 E:665 ||| JJ
radical  ||| S:665 E:673 ||| JJ
by  ||| S:673 E:676 ||| IN
50 ||| S:676 E:678 ||| CD
% ||| S:678 E:679 ||| NN
,  ||| S:679 E:681 ||| ,
TEC50 ||| S:681 E:686 ||| NNP
,  ||| S:686 E:688 ||| ,
min ||| S:688 E:691 ||| CD
)  ||| S:691 E:693 ||| -RRB-
or  ||| S:693 E:696 ||| CC
thermodynamics  ||| S:696 E:711 ||| NN
of  ||| S:711 E:714 ||| IN
the  ||| S:714 E:718 ||| DT
thioamides  ||| S:718 E:729 ||| JJ
reaction  ||| S:729 E:738 ||| NN
with  ||| S:738 E:743 ||| IN
molecular  ||| S:743 E:753 ||| JJ
iodine  ||| S:753 E:760 ||| NNS
( ||| S:760 E:761 ||| -LRB-
extent  ||| S:761 E:768 ||| NN
of  ||| S:768 E:771 ||| IN
thioamide  ||| S:771 E:781 ||| JJ
conversion ||| S:781 E:791 ||| NN
,  ||| S:791 E:793 ||| ,
% ||| S:793 E:794 ||| NN
) ||| S:794 E:795 ||| -RRB-
.  ||| S:795 E:797 ||| .
To  ||| S:797 E:800 ||| TO
compare  ||| S:800 E:808 ||| VB
the  ||| S:808 E:812 ||| DT
antioxidant  ||| S:812 E:824 ||| JJ
activity  ||| S:824 E:833 ||| NN
of  ||| S:833 E:836 ||| IN
thioamides  ||| S:836 E:847 ||| NN
and  ||| S:847 E:851 ||| CC
widely  ||| S:851 E:858 ||| RB
used  ||| S:858 E:863 ||| VBN
standard-antioxidant  ||| S:863 E:884 ||| JJ
Trolox  ||| S:884 E:891 ||| NNP
( ||| S:891 E:892 ||| -LRB-
6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic  ||| S:892 E:943 ||| NNP
acid ||| S:943 E:947 ||| NN
)  ||| S:947 E:949 ||| -RRB-
we  ||| S:949 E:952 ||| PRP
have  ||| S:952 E:957 ||| VBP
proposed  ||| S:957 E:966 ||| VBN
to  ||| S:966 E:969 ||| TO
use  ||| S:969 E:973 ||| VB
a  ||| S:973 E:975 ||| DT
value  ||| S:975 E:981 ||| NN
of  ||| S:981 E:984 ||| IN
relative  ||| S:984 E:993 ||| JJ
antioxidant  ||| S:993 E:1005 ||| JJ
activity  ||| S:1005 E:1014 ||| NN
constant ||| S:1014 E:1022 ||| NN
.  ||| S:1022 E:1024 ||| .
As  ||| S:1024 E:1027 ||| IN
it  ||| S:1027 E:1030 ||| PRP
was  ||| S:1030 E:1034 ||| VBD
established ||| S:1034 E:1045 ||| VBN
,  ||| S:1045 E:1047 ||| ,
the  ||| S:1047 E:1051 ||| DT
kinetics  ||| S:1051 E:1060 ||| NN
of  ||| S:1060 E:1063 ||| IN
interaction  ||| S:1063 E:1075 ||| NN
between  ||| S:1075 E:1083 ||| IN
the  ||| S:1083 E:1087 ||| DT
chromogenic  ||| S:1087 E:1099 ||| JJ
radical  ||| S:1099 E:1107 ||| JJ
and  ||| S:1107 E:1111 ||| CC
thioamides  ||| S:1111 E:1122 ||| NN
in  ||| S:1122 E:1125 ||| IN
the  ||| S:1125 E:1129 ||| DT
presence  ||| S:1129 E:1138 ||| NN
of  ||| S:1138 E:1141 ||| IN
an  ||| S:1141 E:1144 ||| DT
excess  ||| S:1144 E:1151 ||| NN
of  ||| S:1151 E:1154 ||| IN
2,2 ||| S:1154 E:1157 ||| NNP
' ||| S:1157 E:1158 ||| POS
-diphenyl-1-picrylhydrazyl  ||| S:1158 E:1185 ||| NNP
( ||| S:1185 E:1186 ||| -LRB-
DPPH ||| S:1186 E:1190 ||| NNP
)  ||| S:1190 E:1192 ||| -RRB-
is  ||| S:1192 E:1195 ||| VBZ
described  ||| S:1195 E:1205 ||| VBN
by  ||| S:1205 E:1208 ||| IN
the  ||| S:1208 E:1212 ||| DT
kinetics  ||| S:1212 E:1221 ||| NN
of  ||| S:1221 E:1224 ||| IN
the  ||| S:1224 E:1228 ||| DT
pseudo  ||| S:1228 E:1235 ||| JJ
first  ||| S:1235 E:1241 ||| JJ
order  ||| S:1241 E:1247 ||| NN
with  ||| S:1247 E:1252 ||| IN
respect  ||| S:1252 E:1260 ||| NN
to  ||| S:1260 E:1263 ||| TO
the  ||| S:1263 E:1267 ||| DT
reacting  ||| S:1267 E:1276 ||| JJ
components ||| S:1276 E:1286 ||| NNS
.  ||| S:1286 E:1288 ||| .
A  ||| S:1288 E:1290 ||| DT
kinetic-spectrophotometric  ||| S:1290 E:1317 ||| JJ
method  ||| S:1317 E:1324 ||| NN
for  ||| S:1324 E:1328 ||| IN
the  ||| S:1328 E:1332 ||| DT
quantification  ||| S:1332 E:1347 ||| NN
of  ||| S:1347 E:1350 ||| IN
heteroaromatic  ||| S:1350 E:1365 ||| JJ
thioamides  ||| S:1365 E:1376 ||| NN
is  ||| S:1376 E:1379 ||| VBZ
elaborated  ||| S:1379 E:1390 ||| VBN
and  ||| S:1390 E:1394 ||| CC
was  ||| S:1394 E:1398 ||| VBD
tested  ||| S:1398 E:1405 ||| VBN
in  ||| S:1405 E:1408 ||| IN
the  ||| S:1408 E:1412 ||| DT
analysis  ||| S:1412 E:1421 ||| NN
of  ||| S:1421 E:1424 ||| IN
urine ||| S:1424 E:1429 ||| NN
.  ||| S:1429 E:1431 ||| .
Thioamides  ||| S:1431 E:1442 ||| NNP
were  ||| S:1442 E:1447 ||| VBD
detected  ||| S:1447 E:1456 ||| VBN
at  ||| S:1456 E:1459 ||| IN
concentrations  ||| S:1459 E:1474 ||| NNS
of  ||| S:1474 E:1477 ||| IN
1.53μgml ||| S:1477 E:1485 ||| NNP
( ||| S:1485 E:1486 ||| -LRB-
-1 ||| S:1486 E:1488 ||| NNP
) ||| S:1488 E:1489 ||| -RRB-
,  ||| S:1489 E:1491 ||| ,
RSD=4.6 ||| S:1491 E:1498 ||| CD
%  ||| S:1498 E:1500 ||| NN
( ||| S:1500 E:1501 ||| -LRB-
2-mercaptoimidazole ||| S:1501 E:1520 ||| NNP
,  ||| S:1520 E:1522 ||| ,
V ||| S:1522 E:1523 ||| NNP
) ||| S:1523 E:1524 ||| -RRB-
,  ||| S:1524 E:1526 ||| ,
2.08μgml ||| S:1526 E:1534 ||| NNP
( ||| S:1534 E:1535 ||| -LRB-
-1 ||| S:1535 E:1537 ||| NNP
) ||| S:1537 E:1538 ||| -RRB-
,  ||| S:1538 E:1540 ||| ,
RSD=1.8 ||| S:1540 E:1547 ||| CD
%  ||| S:1547 E:1549 ||| NN
( ||| S:1549 E:1550 ||| -LRB-
1-methylimidazoline-2-thione ||| S:1550 E:1578 ||| NNP
,  ||| S:1578 E:1580 ||| ,
VI ||| S:1580 E:1582 ||| NNP
) ||| S:1582 E:1583 ||| -RRB-
,  ||| S:1583 E:1585 ||| ,
1.45μgml ||| S:1585 E:1593 ||| NNP
( ||| S:1593 E:1594 ||| -LRB-
-1 ||| S:1594 E:1596 ||| NNP
) ||| S:1596 E:1597 ||| -RRB-
,  ||| S:1597 E:1599 ||| ,
RSD=4.3 ||| S:1599 E:1606 ||| CD
%  ||| S:1606 E:1608 ||| NN
( ||| S:1608 E:1609 ||| -LRB-
2-mercaptopyridine ||| S:1609 E:1627 ||| NNP
,  ||| S:1627 E:1629 ||| ,
IX ||| S:1629 E:1631 ||| CD
) ||| S:1631 E:1632 ||| -RRB-
.The  ||| S:1632 E:1637 ||| VBZ
proposed  ||| S:1637 E:1646 ||| VBN
procedures  ||| S:1646 E:1657 ||| NNS
show  ||| S:1657 E:1662 ||| VBP
good  ||| S:1662 E:1667 ||| JJ
precision  ||| S:1667 E:1677 ||| NN
and  ||| S:1677 E:1681 ||| CC
accuracy  ||| S:1681 E:1690 ||| NN
of  ||| S:1690 E:1693 ||| IN
the  ||| S:1693 E:1697 ||| DT
results  ||| S:1697 E:1705 ||| NNS
obtained ||| S:1705 E:1713 ||| VBD
.  ||| S:1713 E:1715 ||| .
